Drugs Made In America Acquisition II Corp. Unit

Share · KYG2851K1206 · DMIIU (XNAS)

No Price

13.03.2026 13:30

Current Prices from Drugs Made In America Acquisition II Corp. Unit

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DMIIU	USD	13.03.2026 13:30	10,00 USD	-
IEX	DMIIU	USD	11.03.2026 19:58	10,04 USD	-

Share Float & Liquidity

Free Float 93,08 %

Shares Float 58,66 M

Shares Outstanding 63,02 M

Company Profile for Drugs Made In America Acquisition II Corp. Unit Share

A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.

AI Analysis of Drugs Made In America Acquisition II Corp. Unit

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Drugs Made In America Acquisition II Corp. Unit

No AI threads available for this company yet.

Company Data

Name Drugs Made In America Acquisition II Corp. Unit

Company Drugs Made In America Acquisition II Corp. Unit

Symbol DMIIU

Website https://dmaacorp.com/

Primary Exchange

NASDAQ

ISIN KYG2851K1206

Asset Class Share

Sector Financial Services

Industry Asset Management

CEO Lynn Stockwell

Market Capitalization 630 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1 East Broward Boulevard, 33301 Fort Lauderdale

IPO Date 2025-09-25

Ticker Symbols

Name	Symbol
NASDAQ	DMIIU

More Shares

Investors who hold Drugs Made In America Acquisition II Corp. Unit also have the following shares in their portfolio:

LB.HESS.THR. IHS 21/27 Bond

NOGAHOL.SUK. 21/29 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog